Table 1.
The 62 glioma patients’ classified statistic according to clinical pathological features.
| Factor | Variable | N (%) | Mean IOD of netrin-1 (Mean ± SEM) | p value* |
|---|---|---|---|---|
| Histology | Low grade | 33 (53.2%) | 16124.4309 ± 1645.7586 | 0.0001a |
| High grade | 29 (46.8%) | 29621.221 ± 3218.8488 | ||
| Ki-67 | <10% | 34 (54.8%) | 17153.18 ± 1780.11923 | 0.001a |
| ≥10% | 23 (37.1%) | 31713.15 ± 3833.27060 | ||
| no data | 5 (8.1%) | 20022.03 ± 5990.74457 | ||
| Grade | I | 6 (9.7%) | 10757.63 ± 2940.58031 | 0.002b |
| II | 27 (43.5%) | 17317.0533 ± 1844.97835 | ||
| III | 10 (16.1%) | 26216.543 ± 6649.36802 | ||
| IV | 19 (30.7%) | 31413.1568 ± 3528.05192 | ||
| Gender | Female | 28 (45.2%) | 25397.0711 ± 3513.94286 | 0.166a |
| Male | 34 (54.8%) | 20000.1071 ± 1958.32778 | ||
| Age | <30 | 20 (32.3%) | 20962.1115 ± 3640.92443 | 0.881b |
| 30–60 | 36 (58%) | 22777.7208 ± 2589.15001 | ||
| >60 | 3 (4.8%) | 25313.575 ± 4097.56715 | ||
| MGMT | − | 6 (9.7%) | 20737.1467 ± 3889.47198 | 0.819a |
| + | 56 (90.3%) | 22261.9496 ± 2172.64999 |
aStudent’s t-test; bOne-way ANOVA.